Style | Citing Format |
---|---|
MLA | Jalilian N, et al.. "Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations." Gene, vol. 574, no. 2, 2015, pp. 302-307. |
APA | Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Emamdjomeh H, Nooridaloii MR (2015). Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations. Gene, 574(2), 302-307. |
Chicago | Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Emamdjomeh H, Nooridaloii MR. "Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations." Gene 574, no. 2 (2015): 302-307. |
Harvard | Jalilian N et al. (2015) 'Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations', Gene, 574(2), pp. 302-307. |
Vancouver | Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Emamdjomeh H, Nooridaloii MR. Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations. Gene. 2015;574(2):302-307. |
BibTex | @article{ author = {Jalilian N and Tabatabaiefar MA and Farhadi M and Bahrami T and Emamdjomeh H and Nooridaloii MR}, title = {Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations}, journal = {Gene}, volume = {574}, number = {2}, pages = {302-307}, year = {2015} } |
RIS | TY - JOUR AU - Jalilian N AU - Tabatabaiefar MA AU - Farhadi M AU - Bahrami T AU - Emamdjomeh H AU - Nooridaloii MR TI - Molecular and Clinical Characterization of Waardenburg Syndrome Type I in an Iranian Cohort With Two Novel Pax3 Mutations JO - Gene VL - 574 IS - 2 SP - 302 EP - 307 PY - 2015 ER - |